These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1749 related items for PubMed ID: 18639220

  • 1. Combined fluocinolone acetonide intraocular delivery system insertion, phacoemulsification, and intraocular lens implantation for severe uveitis.
    Chieh JJ, Carlson AN, Jaffe GJ.
    Am J Ophthalmol; 2008 Oct; 146(4):589-594. PubMed ID: 18639220
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study.
    Jaffe GJ, Martin D, Callanan D, Pearson PA, Levy B, Comstock T, Fluocinolone Acetonide Uveitis Study Group.
    Ophthalmology; 2006 Jun; 113(6):1020-7. PubMed ID: 16690128
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Safety and efficacy of intraoperative intravitreal injection of triamcinolone acetonide injection after phacoemulsification in cases of uveitic cataract.
    Dada T, Dhawan M, Garg S, Nair S, Mandal S.
    J Cataract Refract Surg; 2007 Sep; 33(9):1613-8. PubMed ID: 17720079
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Surgical outcomes of combined phacoemulsification and glaucoma drainage implant surgery for Asian patients with refractory glaucoma with cataract.
    Chung AN, Aung T, Wang JC, Chew PT.
    Am J Ophthalmol; 2004 Feb; 137(2):294-300. PubMed ID: 14962420
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Intraocular pressure outcome of patients with fluocinolone acetonide intravitreal implant for noninfectious uveitis.
    Bollinger K, Kim J, Lowder CY, Kaiser PK, Smith SD.
    Ophthalmology; 2011 Oct; 118(10):1927-31. PubMed ID: 21652079
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of an intravitreal fluocinolone acetonide implant versus standard systemic therapy in noninfectious posterior uveitis.
    Pavesio C, Zierhut M, Bairi K, Comstock TL, Usner DW, Fluocinolone Acetonide Study Group.
    Ophthalmology; 2010 Mar; 117(3):567-75, 575.e1. PubMed ID: 20079922
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Intraoperative use of intravitreal triamcinolone in uveitic eyes having cataract surgery: pilot study.
    Okhravi N, Morris A, Kok HS, Menezo V, Dowler JG, Hykin PG, Lightman S.
    J Cataract Refract Surg; 2007 Jul; 33(7):1278-83. PubMed ID: 17586387
    [Abstract] [Full Text] [Related]

  • 15. Risk factors associated with intraocular pressure increase in patients with uveitis treated with the fluocinolone acetonide implant.
    Parekh A, Srivastava S, Bena J, Albini T, Nguyen QD, Goldstein DA.
    JAMA Ophthalmol; 2015 May; 133(5):568-73. PubMed ID: 25719937
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of intractable posterior uveitis in pediatric patients with the fluocinolone acetonide intravitreal implant (Retisert).
    Patel CC, Mandava N, Oliver SC, Braverman R, Quiroz-Mercado H, Olson JL.
    Retina; 2012 Mar; 32(3):537-42. PubMed ID: 21963487
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 88.